# Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut

> **NCT07305090** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 90 (estimated)

## Conditions studied

- Blood Cancer

## Interventions

- **OTHER:** Adult and pediatric patients with hematological diseases treated with allogeneic hematopoietic cell transplantation

## Key facts

- **NCT ID:** NCT07305090
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2027-10-15
- **Final completion:** 2028-02-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305090, "Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07305090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*